Novel combination therapy shows promise for aggressive lymphoma resistant to immunotherapy
by American Association for Cancer Research edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: SHVETS production from Pexels A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the body’s natural response to viral infections, shows promising results in patients with relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), […]
